Mehdi Hamadani, MD(@MediHumdani) 's Twitter Profileg
Mehdi Hamadani, MD

@MediHumdani

BMT & Cellular Therapy | Secretary @ASTCT | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Physician not Provider | 🇵🇰 🏏 🇺🇸 🏈

ID:1424156964

calendar_today12-05-2013 22:40:18

7,4K Tweets

10,6K Followers

3,0K Following

Follow People
Nausheen Ahmed MD(@NausheenAhmedMD) 's Twitter Profile Photo

How does and in access affect outcomes? See below for our editorial on factors behind “race” as a barrier. 👇Race symbolizes structural barriers to timely access .. which can impact outcomes. Natalie Grover, MD . sciencedirect.com/science/articl….

How does #racial and #social #disparities in #CArT access affect outcomes? See below for our editorial on factors behind “race” as a barrier. 👇Race symbolizes structural barriers to timely access .. which can impact outcomes. @NatalieGroverMD . sciencedirect.com/science/articl….
account_circle
Andre Williams(@AndreWi54721839) 's Twitter Profile Photo

Indian American Cancer Scientists awarded by SAASCR for their novel discoveries - IndiaPost NewsPaper - Congrats ⁦Mehdi Hamadani, MD⁩! 🎉🎉🎉 indiapost.com/indian-america…

account_circle
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰(@szusmani) 's Twitter Profile Photo

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma - congrats to my star fellow ⁦Ross Firestone for another excellent⁩ paper ⁦Memorial Sloan Kettering Cancer Center⁩ pubmed.ncbi.nlm.nih.gov/38728378/

account_circle
ASH(@ASH_hematology) 's Twitter Profile Photo

ASH is heading to the hill tomorrow to with a focus on preventing , gaining support for the Comprehensive Care Act (H.R. 7432) & stopping . Follow along with us tomorrow for updates!

ASH is heading to the hill tomorrow to #Fight4Hematology with a focus on preventing #DrugShortages, gaining support for the #SickleCell Comprehensive Care Act (H.R. 7432) & stopping #Medicare #PhysicianPayCuts. Follow along with us tomorrow for updates!
account_circle
Binod Dhakal(@bhemato) 's Twitter Profile Photo

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival ⁦Marcelo Pasquini⁩ ⁦MCW Cancer Center⁩ pubmed.ncbi.nlm.nih.gov/38701390/

account_circle
Mehdi Hamadani, MD(@MediHumdani) 's Twitter Profile Photo

CAR T-cell Therapy in Mantle cell with sCNS Involvement.
Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance?
Mazyar Shadman, MD MPH Gulrayz Ahmed Farrukh Awan Tim Fenske Madiha Iqbal MD Mohamed Kharfan-Dabaja, MD, MBA MCW Cancer Center
ashpublications.org/bloodadvances/…

account_circle
Krishna Komanduri, MD, FASTCT(@drkomanduri) 's Twitter Profile Photo

Flying home after a spectacular ASTCT leadership course. One of the many enlightening moments was a series of talks and panel discussion about leadership challenges by three hematology and cell therapy masters, Mary Horowitz, Brian J. Bolwell, MD and Fred LeMaistre Sarah Cannon Docs.

Flying home after a spectacular @ASTCT leadership course. One of the many enlightening moments was a series of talks and panel discussion about leadership challenges by three hematology and cell therapy masters, @bmtdata, @BrianBolwellMD and Fred LeMaistre @SarahCannonDocs.
account_circle